分子诊断杂志 SCIE

期刊简介预计审稿时间： 较慢,6-12周

The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology (AMP), co-owned by the American Society for Investigative Pathology (ASIP), seeks to publish high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The editors welcome for review articles that contain: novel discoveries or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, clinical informatics, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods which may be applied to diagnosis or monitoring of disease or disease predisposition.

《分子诊断学杂志》是分子病理学协会 (AMP) 的官方出版物，由美国病理学研究协会 (ASIP) 共同拥有，旨在发表高质量的原创论文，内容涉及将医学分子发现转化为临床诊断环境并加以验证的科学进展，以及分子诊断医学领域技术进步的描述和应用。编辑欢迎包含以下内容的评论文章：新发现或临床病理相关性，包括肿瘤学、传染病、遗传性疾病、疾病易感性、临床信息学研究，或与疾病状态或正常变异相关的多态性的描述；诊断方法在临床试验中的应用；或可用于诊断或监测疾病或疾病易感性的新型或改良分子方法的开发。

《Journal Of Molecular Diagnostics》(分子诊断杂志)编辑部通讯方式为AMER SOC INVESTIGATIVE PATHOLOGY, INC, 9650 ROCKVILLE PIKE, BETHESDA, USA, MD, 20814-3993。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。